Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
3
119th Congress
Top supporter
Darline Graham
100% support rate
Top opponent
Ashley Moody
18% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in United States

Legislators moving healthcare in United States
Legislator Party Stance Support rate Decisive votes
Darline Graham
Darline Graham Senate
R
Strong +
100% 6
AA
Alan Armstrong Senate
R
Strong +
88% 8
Peter Welch
Peter Welch Senate
D
Strong +
82% 22
Ron Wyden
Ron Wyden Senate
D
Support
77% 22
Alex Padilla
Alex Padilla Senate
D
Support
76% 21
Ashley Moody
Ashley Moody Senate
R
Strong −
18% 22
Rick Scott
Rick Scott Senate
R
Strong −
18% 22
Rand Paul
Rand Paul Senate
R
Oppose
23% 22
Brad Knott
Brad Knott House · District 13
R
Oppose
28% 18
Pat Harrigan
Pat Harrigan House · District 10
R
Oppose
28% 18
Showing 3 of 3 bills

All healthcare bills

in committee · United States · House Jul 16, 2026

HR 9237: Take Care of America’s Veterans Act

The Take Care of America's Veterans Act is a comprehensive legislative bill designed to improve benefits, healthcare access, and administrative efficiency for veterans and their families. The bill directly affects veterans, their surviving spouses, caregivers, and the Department of Veterans Affairs (VA). Key provisions include expanding disability compensation for combat-related retirees, allowing remarried surviving spouses to retain certain survivor benefits, and increasing compensation rates for specific disability conditions like sleep apnea and tinnitus. The legislation also mandates significant healthcare improvements, such as establishing a pilot program to coordinate care between the VA and Medicare, creating a formulary for prosthetic items, and requiring the VA to provide lactation spaces in all medical centers. Additionally, the bill introduces administrative reforms to speed up claims processing, prohibit denying claims solely for missed medical appointments, and enhance oversight of the VA's disability rating system.
passed · United States · House Jan 15, 2026

HR 7006: Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026

# Summary of U.S. Department of State, Foreign Operations, and Related Programs Appropriations Bill This document is a comprehensive federal appropriations bill for the Department of State, foreign operations, and related programs for fiscal year 2026. It contains detailed provisions governing the allocation, use, and reporting requirements for foreign assistance funds. ## Key Provisions 1. **Funding Restrictions**: - Prohibits funding for abortions as a method of family planning or involuntary sterilization - Bans direct assistance to governments of Cuba, North Korea, or Iran - Prohibits assistance to countries that have experienced a military coup d'état - Restricts assistance to countries in default on U.S. loans - Prohibits funding for countries supporting international terrorism 2. **Notification Requirements**: - Mandates 15-day advance notification to Congress for program changes exceeding $1 million or 10% - Requires prior consultation for major program changes or reprogramming - Requires notification for assistance to specific countries including Afghanistan, Iran, Syria, and others 3. **Funding Allocation Rules**: - Specifies minimum funding levels for various programs - Limits deviations from designated amounts to 10% (up to 50% for national security emergencies) - Requires detailed reports on fund allocation at program, project, and activity levels 4. **Prohibited Expenditures**: - Bans first-class travel in contravention of federal regulations - Prohibits use of funds for tobacco promotion - Restricts use of funds for entertainment at recreational events - Requires computer network filters to block sexually explicit websites 5. **Reporting and Transparency**: - Requires posting of reports on public websites within 45 days - Mandates detailed beneficiary feedback collection for assistance programs - Requires impact evaluations of foreign assistance programs - Requires coordination of foreign assistance with Department of State programs 6. **Transfer Authorities**: - Allows limited transfers between appropriations accounts (up to 5%) - Requires prior consultation for significant transfers - Prohibits transfers to other departments without specific authorization This bill represents a comprehensive framework for U.S. foreign assistance, emphasizing accountability, transparency, national security considerations, and restrictions on certain types of funding. It contains numerous specific prohibitions and requirements aimed at ensuring U.S. foreign aid serves American interests while adhering to specific policy constraints.
signed · United States · Senate Jul 16, 2025

S 331: HALT Fentanyl Act

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.